Reversal of cocaine-induced planarian behavior by parthenolide and related sesquiterpene lactones

Pharmacology Biochemistry and Behavior

Volumn 89, Issue 2, 2008, Pages 160-170

  Pagán, Oné R ^a   Rowlands, Amanda L ^a   Azam, Mahrukh ^a   Urban, Kimberly R ^a   Bidja, Apurva H ^a   Roy, Danielle M ^a   Feeney, Ryan B ^a   Afshari, Lilly K ^a  

^a WEST CHESTER UNIVERSITY   (United States)

Author keywords

Eudesmol; Cocaine; Costunolide; Parthenolide; Planaria; Santonin

Indexed keywords

BETA EUDESMOL; COCAINE; COSTUNOLIDE; PARTHENOLIDE; SANTONIN;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; EXPOSURE; HYPERKINESIA; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; MOTOR PERFORMANCE; NONHUMAN; PRIORITY JOURNAL; TURBELLARIA;

ALGORITHMS; ANIMALS; BEHAVIOR, ANIMAL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; COCAINE; DOPAMINE UPTAKE INHIBITORS; DOSE-RESPONSE RELATIONSHIP, DRUG; HYPERKINESIS; MASS SPECTROMETRY; MOTOR ACTIVITY; PLANARIANS; SANTONIN; SESQUITERPENES; SESQUITERPENES, EUDESMANE; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION;

PLANARIA; TURBELLARIA;

EID: 39149087346     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pbb.2007.12.008     Document Type: Article

References (61)

1. Birladeanu L. The stories of santonin and santonic acid. Angew Chem Int Ed Engl 42 (2003) 1202-1208
2. Bocca C., Gabriel L., Bozzo F., and Miglietta A. A sesquiterpene lactone, costunolide, interacts with microtubule protein and inhibits the growth of MCF-7 cells. Chem Biol Interact 147 (2004) 79-86
3. Buttarelli F.R., Pontieri F.E., Margotta V., and Palladini G. Acetylcholine:dopamine interaction in planaria. Comparative Biochemistry and Physiology Part C 125 (2000) 225-231
4. Buttarelli F.R., Pontieri F.E., Margotta V., and Palladini G. Cannabinoid-induced stimulation of motor activity in planaria through an opioid receptor-mediated mechanism. Prog Neuropsychopharmacol Biol Psychiatry 26 (2002) 65-68
5. Carolei A., Margotta V., and Palladini G. Proposal of a new model with dopaminergic-cholinergic interactions for neuropharmacological investigations. Neuropsychobiology 1 (1975) 355-364
6. Carrera M.R., Trigo J.M., Wirsching P., Roberts A.J., and Janda K.D. Evaluation of the anticocaine monoclonal antibody GNC92H2 as an immunotherapy for cocaine overdose. Pharmacol Biochem Behav 81 (2005) 709-714
7. Cebrià F. Regenerating the central nervous system: how easy for planarians!. Dev Genes Evol (2007 Nov 13) [Epub ahead of print]
8. Cebrià F., Kudome T., Nakazawa M., Mineta K., Ikeo K., Gojobori T., et al. The expression of neural-specific genes reveals the structural and molecular complexity of the planarian central nervous system. Mechanisms of Development 116 (2002) 199-204
9. Chiou L.C., Ling J.Y., and Chang C.C. Beta-Eudesmol as an antidote for intoxication from organophosphorus anticholinesterase agents. Eur J Pharmacol 292 (1995) 151-156
10. Cobbett P., and Day T.A. Functional voltage-gated Ca2+ channels in muscle fibers of the platyhelminth Dugesia tigrina. Comp Biochem Physiol A Mol Integr Physiol 134 (2003) 593-605
11. Day T.A., Haithcock J., Kimber M., and Maule A.G. Functional ryanodine receptor channels in flatworm muscle fibres. Parasitology 120 (2000) 417-422
12. Fairbrothers D.E., Mabry T.J., Scogin R.L., and Turner B.L. The basis of angiosperm phylogeny: chemotaxonomy. Annals of the Missouri Botanical Garden 62 (1975) 765-800
13. Fischer N.H., Lu T., Cantrell C.L., Castaneda-Acosta J., Quijano L., and Franzblau S.G. Antimycobacterial evaluation of germacranolides. Phytochemistry 49 (1998) 559-564
14. Fraga B. Natural sesquiterpenoids. Nat Prod Rep 19 (2002) 650-672
15. Hoffman R.S., Kaplan J.L., Hung O.L., and Goldfrank L.R. Ecgonine methyl ester protects against cocaine lethality in mice. J Toxicol Clin Toxicol 42 (2004) 349-354
16. Jenkins M.M. Aspects of planarian biology and behavior. In: Corning W., and Ratner S. (Eds). The chemistry of learning: invertebrate research (1967), Plenum Publishing Corp, New York 116-143
17. Kimura M., Nojima H., Muroi M., and Kimura I. Mechanism of the blocking action of beta-eudesmol on the nicotinic acetylcholine receptor channel in mouse skeletal muscles. Neuropharmacology 30 (1991) 835-841
18. Kitamura Y., Kakimura J., and Taniguchi T. Protective effect of talipexole on MPTP-treated planarian, a unique parkinsonian worm model. Jpn J Pharmacol 78 (1998) 23-29
19. Kreek M.J., Bart G., Lilly C., LaForge K.S., and Nielsen D.A. Pharmacogenetics and human molecular genetics of opiate and cocaine addictions and their treatments. Pharmacol Rev 57 (2005) 1-26
20. Kwok B.H., Koh B., Ndubuisi M.I., Elofsson M., and Crews C.M. The anti-inflammatory natural product parthenolide from the medicinal herb Feverfew directly binds to and inhibits IkappaB kinase. Chem Biol 8 (2001) 759-766
21. Kusayama T., and Watanabe S. Reinforcing effects of methamphetamine in planarians. Neuroreport 11 (2000) 2511-2513
22. Macías F.A., Galindo J.C., Castellano D., and Velasco R.F. Sesquiterpene lactones with potential use as natural herbicide models (I): trans,trans-germacranolides. J Agric Food Chem 47 (1999) 4407-4414
23. Margotta V., Caronti B., Meco G., Merante A., Ruggieri S., Venturini G., et al. Effects of cocaine treatment on the nervous system of planaria (Dugesia gonocephala s.l.). Histochemical and ultrastructural observations. Eur J Histochem 41 (1997) 223-230
24. Marles R.J., Kaminski J., Arnason J.T., Pazos-Sanou L., Heptinstall S., Fischer N.H., et al. A bioassay for inhibition of serotonin release from bovine platelets. J Nat Prod 55 (1992) 1044-1056
25. Martell B.A., Mitchell E., Poling J., Gonsai K., and Kosten T.R. Vaccine pharmacotherapy for the treatment of cocaine dependence. Biol Psychiatry 15 (2005) 158-164
26. Meltzer P.C., Liu S., Blanchette H., Blundell P., and Madras B.K. Design and synthesis of an irreversible dopamine-sparing cocaine antagonist. Bioorg Med Chem 10 (2002) 3583-3591
27. Miglietta A., Bozzo F., Gabriel L., and Bocca C. Microtubule-interfering activity of parthenolide. Chem Biol Interact 149 (2004) 165-173
28. Motulsky H. Intuitive biostatistics (1995), Oxford University Press, New York, NY
29. Motulsky H. Analyzing data with GraphPad Prism (1999), GraphPad Software Inc, San Diego, CA
30. Nakazawa M., Cebrià F., Mineta K., Ikeo K., Agata K., and Gojobori T. Search for the evolutionary origin of a brain: planarian brain characterized by microarray. Mol Biol Evol 20 (2003) 784-791
31. Nam N.H. Naturally occurring NF-kappaB inhibitors. Mini Rev Med Chem 6 (2006) 945-951
32. Needleman H.L. Tolerance and dependence in the planarian after continuous exposure to morphine. Nature 215 (1967) 784-785
33. Newmark P.A., and Sánchez Alvarado A. Not your father's planarian: a classic model enters the era of functional genomics. Nat Rev Genet 3 (2002) 210-219
34. Nishimura K., Kitamura Y., Inoue T., Umesono Y., Sano S., Yoshimoto K., et al. Reconstruction of dopaminergic neural network and locomotion function in planarian regenerates. Dev Neurobiol 67 (2007) 1059-1078
35. Pagán O.R. Synthetic local anesthetics as alleviators of cocaine inhibition of the human dopamine transporter. Chapter 5 - Perspectives. PhD Dissertation (2005), Cornell University, Ithaca, NY
36. Pagán O.R., Rowlands A.L., and Urban K.R. Toxicity and behavioral effects of dimethylsulfoxide in planaria. Neurosci Lett 407 (2006) 274-278
37. Palladini G., Ruggeri S., Stocchi F., De Pandis M.F., Venturini G., and Margotta V. A pharmacological study of cocaine activity in planaria. Comp Biochem Physiol C Pharmacol Toxicol Endocrinol 115 (1996) 41-45
38. Pan Y., Gao D., Yang W., Cho H., Yang G., Tai H.H., et al. Computational redesign of human butyrylcholinesterase for anticocaine medication. Proc Natl Acad Sci USA 102 (2005) 16656-16661
39. Pearl R. The movements and reactions of fresh-water planarians: a study on animal behavior. Quart J Microsc Sci 46 (1903) 509-713
40. Raffa R.B., and Desai P. Description and quantification of cocaine withdrawal signs in Planaria. Brain Res 1032 (2005) 200-202
41. Raffa R.B., Holland L.J., and Schulingkamp R.J. Quantitative assessment of dopamine D2 antagonist activity using invertebrate (Planaria) locomotion as a functional endpoint. J Pharmacol Toxicol Methods 45 (2001) 223-226
42. Raffa R.B., and Martley A.F. Amphetamine-induced increase in planarian locomotor activity and block by UV light. Brain Res 1031 (2005) 138-140
43. Raffa R.B., Stagliano G.W., and Tallarida R.J. Subadditive withdrawal from cocaine/kappa-opioid agonist combinations in Planaria. Brain Res 1114 (2006) 31-35
44. Raffa R.B., and Valdez J.M. Cocaine withdrawal in Planaria. Eur J Pharmacol 430 (2001) 143-145
45. Ribeiro P., El-Shehabi F., and Patocka N. Classical transmitters and their receptors in flatworms. Parasitology Suppl (2005) S19-S40
46. Robb S.M., Ross E., and Sánchez Alvarado A. SmedGD: the Schmidtea mediterranea genome database. Nucleic Acids Res (2007) Oct 4:[Epub ahead of print]
47. Rothenfluh A., and Heberlein U. Drugs, flies, and videotape: the effects of ethanol and cocaine on Drosophila locomotion. Curr Opin Neurobiol 12 (2002) 639-645
48. Saitoh O., Yuruzume E., and Nakata H. Identification of planarian serotonin receptor by ligand binding and PCR studies. Neuroreport 8 (1996) 173-178
49. Sarnat H.B., and Netsky M.G. When does a ganglion become a brain? Evolutionary origin of the central nervous system. Semin Pediatr Neurol 9 (2002) 240-253
50. Sarnat H.B., and Netsky M.G. The brain of the planarian as the ancestor of the human brain. Can J Neurol Sci 12 (1985) 296-302
51. Scholz A. Mechanisms of (local) anaesthetics on voltage-gated sodium and other ion channels. Br J Anaesth 89 (2002) 52-61
52. Sofuoglu M., and Kosten T.R. Emerging pharmacological strategies in the fight against cocaine addiction. Expert Opin Emerg Drugs 11 (2006) 91-98
53. Stokely P.S., and Grossi J.C. Observations on the behavior and reconstitution of chlorpromazine-treated planarian (Dugesia tigrina). The Ohio Journal of Science 63 (1963) 290-297
54. Torres G.E., Gainetdinov R.R., and Caron M.G. Plasma membrane monoamine transporters: structure, regulation and function. Nat Rev Neurosci 4 (2003) 13-25
55. Tsuneki H., Ma E.L., Kobayashi S., Sekizaki N., Maekawa K., Sasaoka T., et al. Antiangiogenic activity of beta-eudesmol in vitro and in vivo. Eur J Pharmacol 512 (2005) 105-115
56. Venturini G., Stocchi F., Margotta V., Ruggieri S., Bravi D., Bellantuono P., et al. A pharmacological study of dopaminergic receptors in planaria. Neuropharmacology 28 (1989) 1377-1382
57. Villar D., and Schaeffer D.J. Morphogenetic action of neurotransmitters on regenerating planarians-a review. Biomed Environ Sci 6 (1993) 327-347
58. Weber J.T., O'Connor M.F., Hayataka K., Colson N., Medora R., Russo E.B., et al. Activity of parthenolide at 5HT2A receptors. J Nat Prod 60 (1997) 651-653
59. Wedge D.E., Galindo J.C., and Macías F.A. Fungicidal activity of natural and synthetic sesquiterpene lactone analogs. Phytochemistry 53 (2000) 747-757
60. Weiss J.N. The Hill equation revisited: uses and misuses. FASEB J 11 (1997) 835-841
61. Wolf F.W., and Heberlein U. Invertebrate models of drug abuse. J Neurobiol 54 (2003) 161-178